Run by Former Genentech Employees, Bay Area's Denali Seeks $100M IPO Post author:Sam Post published:November 13, 2017 Post category:BioPharma Denali plans to make a $100M IPO under the symbol DNLI. Source: BioSpace You Might Also Like Safety Concerns Raised as Ionis Pharma's Inotersen Meets Both Primary Endpoints in Late-Stage Study May 14, 2017 What You Need to Know About Fortis Therapeutics January 22, 2018 Catabasis To Present Results From The Open-Label Extension Of The Movedmd Phase II Trial Of Edasalonexent In Duchenne Muscular Dystrophy In A Late Breaking Session Of The World Muscle Society September 14, 2017
Safety Concerns Raised as Ionis Pharma's Inotersen Meets Both Primary Endpoints in Late-Stage Study May 14, 2017
Catabasis To Present Results From The Open-Label Extension Of The Movedmd Phase II Trial Of Edasalonexent In Duchenne Muscular Dystrophy In A Late Breaking Session Of The World Muscle Society September 14, 2017
